Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GDP in Relapsed/Refractory Hodgkin's or Aggressive NHL
NCT00014209Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 2000
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Canadian Cancer Trials Group. Started Dec 2000; status: completed.
02
Drugs
gemcitabine
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00014209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014209.